Fuji Pharma Co., Ltd. (FRA:FUP)

Germany flag Germany · Delayed Price · Currency is EUR
7.75
-0.05 (-0.64%)
At close: Jul 4, 2025, 10:00 PM CET
-7.74%
Market Cap 192.54M
Revenue (ttm) 301.78M
Net Income (ttm) 19.62M
Shares Out n/a
EPS (ttm) 0.81
PE Ratio 9.81
Forward PE n/a
Dividend 0.26 (3.38%)
Ex-Dividend Date Mar 28, 2025
Volume n/a
Average Volume n/a
Open 7.75
Previous Close 7.80
Day's Range 7.75 - 7.75
52-Week Range 7.05 - 10.30
Beta n/a
RSI 44.40
Earnings Date Aug 7, 2025

About Fuji Pharma

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan. [Read more]

Industry Pharmaceutical Preparations
Founded 1965
Employees 1,658
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol FUP
Full Company Profile

Financial Performance

In 2024, Fuji Pharma's revenue was 46.14 billion, an increase of 12.84% compared to the previous year's 40.89 billion. Earnings were 6.15 billion, an increase of 78.92%.

Financial numbers in JPY Financial Statements

News

There is no news available yet.